It’s generally known that Alzheimer’s disease is a neurological condition that primarily targets the brain. However, new information suggests that it actually starts somewhere else in the body. As such, scientists are suggesting to take even better care of one’s physical and mental health to reduce the chances of developing the degenerative condition.
The new data was presented by a joint effort of Canadian and Chinese researchers who posted their findings on the Molecular Psychiatry journal. According to their study, Alzheimer’s might actually start somewhere other than the brain. This is due to how the condition is caused by the build-up of beta-amyloid proteins and tau proteins.
“In this study, using a model of parabiosis between APPswe/PS1dE9 transgenic AD mice and their wild-type littermates, we observed that the human Aβ originated from transgenic AD model mice entered the circulation and accumulated in the brains of wild-type mice, and formed cerebral amyloid angiopathy and Aβ plaques after a 12-month period of parabiosis,” the paper reads.
The key takeaway here is the beta-amyloid build-up because this protein is actually produced by other parts of the body. At any given moment, the human body produces the protein, which then crosses the blood-brain barrier. As a result, the protein gets stuck in the brain, which results in Alzheimer’s.
These findings could result in a huge shift in how the degenerative disease might be approached in the future. Right now, Alzheimer’s treatments largely focus on the brain, Futurism reports. As this study suggests, however, scientists might want to look into other parts of the body. More specifically, perhaps more focus should be given to the build-up of beta-amyloid.
Doing so could finally alleviate the burden that the care of patients with Alzheimer’s or dementia is causing. In 2016 alone, the U.S. has spent $236 billion in caring for such patients.


Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements
Samsung Workers Approve Wage Deal, Avoiding Major Strike and Boosting Chip Supply Confidence
SpaceX IPO Hype Raises Questions as Many Major Stock Debuts Underperform Market
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs
Macquarie Names Five Taiwan AI Stocks Set to Benefit From Data Center Growth in 2026
Samsung Union Dispute Escalates Over Semiconductor Bonus Vote
EU Antitrust Probe Could Lead to Massive Google Fine Under DMA Rules
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
SpaceX IPO Could Become Largest in History with $1.8 Trillion Valuation Target
Snowflake Stock Soars 30% After Q1 Earnings Beat and Major AWS AI Partnership
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt 



